| Name | Title | Contact Details |
|---|
Novocardia is on a mission to transform how cardiovascular disease care is delivered in the United States, and aims to help patients with heart and vascular disease live longer, healthier, and more satisfying lives. We are committed to putting cardiologists, and their patients, at the center of care by investing in our partner practices, deploying purpose-built data and analytics tools to improve patient outcomes, and enabling our partners to transition more successfully to value-based care.
First aid for when fun wins.
Dedicated Phase 1 is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
SynteractHCR is a full-service contract research organization with a successful two-decade track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development.
WellCheck Inc is a Oakland, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.